NeoStem’s (Amex: NBS), Amorcyte awarded Patent
January 10th, 2012
No comments
Amorcyte’s, a NeoStem company (NYSE Amex: NBS) patent award Read more…
Categories: NBS’s Progenitor Cell Therapy (PCT), NeoStem, New Patent
